One-third of folks with major depressive disorder experience treatment-resistant depression (TRD), a condition that makes it ...
The FDA approved Johnson & Johnson’s Spravato nasal spray as a stand-alone treatment for patients suffering from severe depression. It is now the first-ever stand-alone therapy for treatment-resistant ...
US healthcare giant Johnson & Johnson announced the US Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for Spravato (esketamine) CIII nasal spray as the first ...
Inquirer on MSN2d
Ketamine a lifeline for severe depression patients in SingaporeKetamine, the controlled drug best known as a horse tranquilizer or party supplement, has in the last four years become a ...
Kelsey Warren [email protected] 609 218 4053 Investor contact: Lauren Johnson [email protected] ...
Since October 2020 – when the Health Sciences Authority (HSA) first authorized sale of an esketamine nasal ... the cost of oral anti-depressants, which must accompany any Spravato course ...
Once seen as an alternative option, the ketamine nasal spray Spravato is ... The bill does not include the cost of oral anti-depressants, which must accompany any Spravato course, and the talk ...
Drugs used to treat cancer, diabetes and other chronic conditions are among 15 picked for negotiations that could result in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback